Company / FCF Margin
Anika Therapeutics, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
3.9%
FY2025
5-year range
-6.0% / 29.8%
FY2021-FY2025
Trend
+299.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed +299% YoY in FY2025, a notable deviation from the 9-year average annual change of +26%.
Based on SEC 10-K filings.
3.9% in FY2025 with a 5-year CAGR of -24.8%.
Improved from -6.0% to 3.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -4.9pp
- 5-Year Change
- -24.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 299.5% year-over-year.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 3.9% | +299.5% |
| FY2024 | -1.9% | +67.5% |
| FY2023 | -6.0% | -168.1% |
| FY2022 | 8.8% | -70.6% |
| FY2021 | 29.8% | +4.0% |
| FY2020 | 28.7% | +2.1% |
| FY2019 | 28.1% | +178.2% |
| FY2018 | 10.1% | -69.4% |
| FY2017 | 33.0% | -9.3% |
| FY2016 | 36.4% | +10.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026